Azenta (AZTA)
(Delayed Data from NSDQ)
$50.49 USD
-0.68 (-1.33%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $50.43 -0.06 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AZTA 50.49 -0.68(-1.33%)
Will AZTA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AZTA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AZTA
Inspire Medical Systems (INSP) Surpasses Q4 Earnings and Revenue Estimates
Outset Medical, Inc. (OM) Expected to Beat Earnings Estimates: Should You Buy?
AZTA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Health, Inc. (HIMS) Moves 8.3% Higher: Will This Strength Last?
3 Stocks to Watch After Impressive Earnings Beats
Azenta (AZTA) Beats Q3 Earnings and Revenue Estimates
Other News for AZTA
ROBO ETF: A Diversified Investment Into The Future
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Azenta (AZTA) Shares Cross Below 200 DMA
Optimistic Financial Future and Strategic Growth: A Buy Rating for Azenta
Analysts Conflicted on These Healthcare Names: Icon (ICLR), Schrodinger (SDGR) and Azenta (AZTA)